Previous 10 | Next 10 |
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Sera Prognostics Inc. (SERA) is expected to report $-0.3 for Q3 2023
Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023 PR Newswire SALT LAKE CITY , Oct. 25, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), f...
SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023 PR Newswire SALT LAKE CITY , Sept. 21, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal h...
2023-08-11 15:25:24 ET Sera Prognostics, Inc. (SERA) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Peter DeNardo – Investor Relations-CapComm Partners Zhenya Lindgardt – Interim President and Chief Executive Officer ...
2023-08-09 16:28:53 ET Sera Prognostics press release ( NASDAQ: SERA ): Q2 GAAP EPS of -$0.34 in-line. Revenue of $0.12M (+71.4% Y/Y) beats by $0.03M . For further details see: Sera Prognostics GAAP EPS of -$0.34 in-line, revenue of $0.12M beats by $0.03M
SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Aug. 9, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing inno...
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023 PR Newswire SALT LAKE CITY , July 31, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA)...
2023-06-08 18:58:38 ET Summary Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarkers linked to premature birth. Premature birth is a significant issue, with 1 in 10 babies born prema...
Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue PR Newswire Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Mem...
News, Short Squeeze, Breakout and More Instantly...
Sera Prognostics Inc. Company Name:
SERA Stock Symbol:
NASDAQ Market:
Sera Prognostics Inc. Website:
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial PR Newswire Sera Prognostics Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-R...
2024-07-06 13:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION PR Newswire SALT LAKE CITY , July 1, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on ...